The Latest Breaking News from Clinical Trial

Phio Pharmaceuticals Open enrollment in Phase 1b Trial of PH-762 for the Treatment of Advanced Melanoma

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) has started enrolling patients in the Phase 1b clinical trial of PH-762 for the treatment of advanced melanoma.

Benzinga · Apr 26, 2022

Monash IVF Group's 'inaccurate' genetic test potentially robbed these women of viable embryos

IVF is big business in Australia. But in the quest to innovate, one company may have gone too far.

ABC News · Apr 22, 2022

Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp

Three weeks after announcing the results of its preclinical trials for CYB003, Cybin (NYSE:CYBN) made public a partnership with Clinilabs Drug Development Corporation to take the proprietary drug to it

Benzinga · Apr 22, 2022